December 9, 2025

National HealthCare Corporation (NHC): Investor Outlook on a Healthcare Mainstay with a Solid Dividend Yield

National HealthCare Corporation (NHC) stands as a stalwart in the healthcare sector, offering an array of medical care services that cater to a diverse range of..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Strong Buy Ratings and 16% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is drawing considerable attention in the healthcare sector, particularly among investors seeking opportunities in the drug manufacturing space. Specializing in both..

Aurinia Pharmaceuticals Inc (AUPH) Stock Report: Navigating the 6.29% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a prominent player in the biotechnology sector, is garnering attention from investors, particularly with an eye-catching 6.29% potential upside based on..

Veracyte, Inc. (VCYT) Investor Outlook: Unpacking a 7% Upside Potential in Healthcare Diagnostics

Veracyte, Inc. (NASDAQ: VCYT) stands as a notable player in the healthcare diagnostics and research industry, offering a suite of genomic tests designed to improve cancer..

Agios Pharmaceuticals (AGIO) Stock Analysis: High Growth Potential Amidst Revenue Surge and Positive Ratings

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the biotechnology sector with its focus on pioneering treatments for rare genetic diseases through advancements in cellular metabolism...

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 53.57% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector, presents a compelling opportunity for investors, with a potential upside of 53.57% based on its..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook Reveals 39.81% Potential Upside

U.S. Physical Therapy, Inc. (USPH), a prominent player in the healthcare sector, offers a promising investment opportunity with a compelling potential upside of 39.81%. With a..

MiMedx Group, Inc (MDXG) Stock Analysis: A Potential 82% Upside in the Biotech Sector

MiMedx Group, Inc (NASDAQ: MDXG) is making waves in the biotechnology sector with a compelling growth narrative and an impressive potential upside of 82.63%. This Marietta,..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 32.83% Potential Upside for Investors

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands as a compelling player within the biotechnology sector, particularly for investors interested in companies that focus on rare and orphan..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Why a 23.94% Potential Upside Has Investors Buzzing

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector focusing on neurological and psychiatric disorders, has been capturing the attention of investors with..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unveiling a 186.67% Potential Upside in the Biotech Sector

ARS Pharmaceuticals, Inc. (SPRY), a dynamic player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 186.67%. This San Diego-based biopharmaceutical..

Harmony Biosciences Holdings (HRMY): Investor Outlook on a Promising 18.66% Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has emerged as a compelling player in the biotechnology sector, specifically within the healthcare industry. With a market capitalization of..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a 8.60% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a pivotal player in the medical devices industry, stands as a noteworthy contender in the healthcare sector with a market..

PACS Group, Inc. (PACS) Stock Analysis: A Promising 13.82% Upside in the Healthcare Sector

PACS Group, Inc. (PACS), a notable player in the healthcare sector, has been making waves in the medical care facilities industry with its impressive financial growth..

CONMED Corporation (CNMD) Investor Outlook: Evaluating a Potential 23.74% Upside Amidst Market Challenges

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor interest with its compelling growth potential...

Select Medical Holdings Corp (SEM) Stock Analysis: A 23% Potential Upside with Strong Analyst Support

Select Medical Holdings Corporation (NYSE: SEM) is capturing the attention of healthcare investors with its robust market presence and promising growth potential. Operating in the healthcare..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring a Potential 32.82% Upside for Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has been making waves in the biotechnology sector with its innovative immune medicine platform aimed at diagnosing and treating various diseases...

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A 15.76% Upside Potential in the Healthcare Sector

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, is capturing investor attention with its robust growth prospects and diverse service offerings. As..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Reveals a Promising 28.29% Upside Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is capturing the attention of investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 53.87% Upside Potential

Surgery Partners, Inc. (NASDAQ: SGRY) operates within the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of approximately $2.16..

Search

Funds

December 9, 2025

Search

Funds

December 9, 2025

FTSE 100

Funds